Tumor Necrosis Factor -308 and Lymphotoxin+252 Polymorphisms in Mexican Children with Kawasaki Disease and Coronary Aneurysms

Archives of Medical Research

Volumn 42, Issue 7, 2011, Pages 602-607

  Cruz Olivo, Francisco ^a   García Elorriaga, Guadalupe ^b   González Bonilla, César ^b   del Rey Pineda, Guillermo ^b,c   Mancilla Ramírez, Javier ^d  

^a UMAE Hospital General   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^d INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Coronary aneurysm; Genotype; Kawasaki disease; Polymorphism

Indexed keywords

GENOMIC DNA; IMMUNOGLOBULIN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ADOLESCENT; ALLELE; ARTICLE; CHILD; CHILDHOOD DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CROSS-SECTIONAL STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE DRUG DOSE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; CROSS-SECTIONAL STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOTOXIN-ALPHA; MEXICO; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855504711     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.11.002     Document Type: Article

References (33)

1. Burns J.C., Kushner I.H., Bastian J.F., et al. Kawasaki disease: a brief history. Pediatrics 2000, 106:E27.
2. Brogan P.A., Bose A., Burgner D., et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposal for future research. Arch Dis Child 2002, 86:286-290.
3. Pinna G.S., Kafetzis D.A., Tselkas O.I., et al. Kawasaki disease: an overview. Curr Opin Infect Dis 2008, 21:263-270.
4. Onouchi Y. Molecular genetics of Kawasaki disease. Ped Res 2009, 65(5 Pt 2):46R-54R.
5. Wood L.E., Tulloh R.M.R. Kawasaki disease in children. Heart 2009, 95:787-792.
6. Arj-Ong S., Thakkinstian A., McEvoy M., et al. A systematic review and meta-analysis of tumor necrosis factor α -308 polymorphism and Kawasaki disease. Pediatr Int 2010, 52:527-532.
7. Almeida R.G., Goldenzon A.V., Rodrigues M.C., et al. Profile of Kawasaki disease in children referred to two pediatric rheumatology services in Rio de Janeiro, Brazil. Rev Bras Reumatol 2010, 50:529-538.
8. Ahn S.Y., Jang G.C., Shin J.S., et al. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 2003, 44:1021-1026.
9. Alarcón-Viscaino A., Salas-Arévalo A., López-Rodríguez A., et al. Enfermedad de Kawasaki en niños mexicanos. Bol Med Hosp Infant Mex 1991, 48:398-408.
10. González-Galnares M., Vázquez-Urban H., Santamaría-Díaz H., et al. Enfermedad de Kawasaki en México: análisis de 13 casos. Bol Med Hosp Infant Mex 1991, 48:409-416.
11. Cruz N.S., González-Ramos L., Gómez-Rivera N., et al. Enfermedad de Kawasaki. Experiencia en siete niños. Rev Mex Pediatr 2001, 68:189-195.
12. Rodríguez-Carbajal L., Román Z.J., Figueroa L.M., et al. Las vasculitis. Frecuencia en un hospital de tercer nivel. Acta Pediatr Mex 2003, 24:269-278.
13. Burns J.C., Glodé M.P. Kawasaki Syndrome. Lancet 2004, 364:533-544.
14. Pociot F., Briant L., Jongeneel C.V., et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993, 23:224-231.
15. Sirgo G., Rello J., Bodi M., et al. Polimorfismo genético en el paciente crítico (I). Aspectos generales, inflamación y sepsis. Med Intensiva 2003, 27:24-31.
16. Luois E., Franchimont D., Piron A., et al. Tumor necrosis factor (TNF) gene polymorphism influences TNF-(alpha) production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998, 113:401-406.
17. Nedwin G.E., Naylor S.L., Sakaguchi A.Y., et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res 1985, 13:6361-6373.
18. Meenagh A., Williams F., Ross O.A., et al. Frequency of cytokine polymorphism populations from Western Europe, Africa, Asia, the Middle East and South America. Hum Immunol 2002, 63:1055-1061.
19. Chien Y.H., Chang K.W., Yang Y.H., et al. Association between levels of TNF-alpha and promoter polymorphism in children with Kawasaki disease. J Formos Med Assoc 2003, 102:147-150.
20. Cheung Y.F., Huang G.Y., Chen S.B., et al. Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 2008, 122:e608-e614.
21. Lin C.Y., Lin C.C., Hwang B., et al. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur J Pediatr 1993, 152:309-312.
22. Yang J., Li C.R., Li Y.B., et al. The correlation between Kawasaki disease and polymorphisms of tumor necrosis factor alpha and interleukin-10 gene promoter. Zhonghua Er Ke Za Zhi 2003, 41:598-602.
23. Quasney M.W., Bronstein D.E., Cantor R.M., et al. Increased frequency of alleles associated with elevated tumor necrosis factor-α levels in children with Kawasaki disease. Pediatr Res 2001, 49:686-690.
24. Delaney N.L., Esquenazi V., Lucas D.P., et al. TNF-alpha, TGF-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI Minority Workshops: Part IV. Hum Immunol 2004, 65:1413-1419.
25. Newburger J.W., Takahashi M., Gerber A.M., et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease. A Statement for Health Professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association. Pediatrics 2004, 114:1708-1733.
26. Dejani A.S., Taubert K.A., Takahashi M., et al. Guidelines for long-term management of patients with Kawasaki disease. Circulation 1994, 89:916-922.
27. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993, 15:532-537.
28. Roberts A.K., Monzon-Bordonaba F., Van Deerlin P.G., et al. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol 1999, 180:1297-1302.
29. Stuber F., Petersen M., Bokelmann F., et al. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996, 24:381-384.
30. Rodríguez-Carreón A.A., Zúñiga J., Hernández-Pacheco G., et al. Tumor necrosis factor-alpha-308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun 2005, 24:63-68.
31. México D.F. Norma Oficial Mexicana para la Disposición de Sangre Humana y sus componentes con fines terapéuticos. 1993.
32. García-Elorriaga G., Carrillo-Montes G., Mendoza-Aguilar M., et al. Polymorphisms in tumor necrosis factor and lymphotoxin A in tuberculosis without and with response to treatment. Inflammation 2010, 33:267-275.
33. Garza-González E., Bosques-Padilla F.J., El-Omar E., et al. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 2005, 20:237-241.